Pinealon
Also known as: EDR, Glu-Asp-Arg
Key Facts: Pinealon
- Category
- Bioregulators
- FDA Status
- Not FDA Approved
- Clinical Status
- Available in Russia - Not FDA approved
- Administration
- Oral or sublingual
- Typical Dose
- 10-20 mg daily
- Frequency
- Once daily, typically evening
- Evidence Level
- Animal Studies
- Duration
- 10-30 day courses
What to Expect
A synthetic tripeptide bioregulator targeting brain tissue. Part of Khavinson's peptide research, designed to support cognitive function and neuroprotection.
Mechanism of Action
Pinealon regulates gene expression in brain cells, particularly those involved in neuronal survival and function. It modulates melatonin synthesis, supports circadian rhythm, and has antioxidant effects in neural tissue.
Research Summary
Russian studies show neuroprotective effects and cognitive improvement in aging. Research demonstrates protection against hypoxia and oxidative stress. Used in combination with other bioregulator peptides.
Dosing Information
Note: Animal study doses may not translate directly to humans.
Typical Dosingⓘ
Community experience
10-20 mg daily
10-20 mg daily
Once daily, typically evening
Brain bioregulator targeting pineal gland. Take in evening. Part of Khavinson peptide system.
Research Dosingⓘ
Scientific studies
Doses from research protocols
Doses from Studies
10-20 mg daily
Oral capsules or sublingual
Duration
10-30 day courses
Administration
Oral or sublingual
Timing & Administration
Best Time to Take
Evening or before bed
Once daily before bed
Food Recommendation
With or without food
Why This Timing?
Pinealon affects the pineal gland and sleep regulation. Evening use supports natural melatonin.
Possible Side Effects
Not everyone experiences these effects. Individual responses vary based on dosage, duration, and personal factors.
- ●Generally well-tolerated
- ●Headache
- ●Nausea
- ●Dizziness
- ●Vivid dreams
- ●Injection site reactions
- ●Caution with seizure disorders
References
Related Peptides
Peptides commonly compared with Pinealon or used in similar applications.
Epithalon
Clinical TrialsA tetrapeptide studied for its effects on telomerase activation and potential anti-aging properties. Based on research by Professor Vladimir Khavinson.
BioregulatorsCortagen
PreclinicalA tetrapeptide bioregulator (Ala-Glu-Asp-Pro) derived from cerebral cortex extracts. Studied for neuroprotection, neural differentiation, and cognitive support. Regulates neurotrophic signaling and synaptic stability.
BioregulatorsThymalin
Clinical TrialsA thymic peptide complex used in Russia for immune enhancement and anti-aging. Part of Professor Khavinson's bioregulator peptide research.
BioregulatorsVilon
PreclinicalA synthetic dipeptide bioregulator targeting thymic function. Part of Khavinson's peptide bioregulator research for immune and anti-aging effects.
BioregulatorsCartalax
PreclinicalA synthetic tripeptide bioregulator targeting cartilage tissue. Developed for joint health and cartilage regeneration.
BioregulatorsLivagen
PreclinicalA tetrapeptide bioregulator (Lys-Glu-Asp-Ala) developed by Khavinson that modulates chromatin structure and gene expression. Research shows it can decondense heterochromatin and activate ribosomal genes, potentially restoring more youthful gene expression patterns in aging cells.
BioregulatorsWant updates on Pinealon research?
Subscribe to get notified when we add new research findings, protocol updates, and related peptide information.
Educational Information Only
This information is provided for educational purposes only and is not intended as medical advice. Always consult with qualified healthcare providers before making any decisions about peptides or other substances. The protocols listed reflect doses observed in research studies, not recommendations.